Clinical outcomes with extended or continuous versus short-term intravenous infusion of carbapenems and piperacillin/tazobactam: a systematic review and meta …
ME Falagas, GS Tansarli, K Ikawa… - Clinical infectious …, 2013 - academic.oup.com
We sought to study whether the better pharmacokinetic and pharmacodynamic (PK/PD)
properties of carbapenems and piperacillin/tazobactam, when the duration of infusion is …
properties of carbapenems and piperacillin/tazobactam, when the duration of infusion is …
The retrospective cohort of extended‐infusion piperacillin‐tazobactam (RECEIPT) study: a multicenter study
RJ Yost, DM Cappelletty… - … : The Journal of …, 2011 - Wiley Online Library
Study Objective. To compare the effectiveness of extended‐infusion piperacillin‐tazobactam
with that of similar‐spectrum, nonextended‐infusion β‐lactam antibiotics in the treatment of …
with that of similar‐spectrum, nonextended‐infusion β‐lactam antibiotics in the treatment of …
Clinical outcomes with alternative dosing strategies for piperacillin/tazobactam: a systematic review and meta-analysis
H Yang, C Zhang, Q Zhou, Y Wang, L Chen - PloS one, 2015 - journals.plos.org
Objectives A better dosing strategy can improve clinical outcomes for patients. We sought to
compare the extended or continuous infusion with conventional intermittent infusion of …
compare the extended or continuous infusion with conventional intermittent infusion of …
Prolonged infusion piperacillin-tazobactam decreases mortality and improves outcomes in severely ill patients: results of a systematic review and meta-analysis
Objective: Piperacillin-tazobactam is a commonly used antibiotic in critically ill patients;
however, controversy exists as to whether mortality in serious infections can be decreased …
however, controversy exists as to whether mortality in serious infections can be decreased …
Outcomes of extended infusion piperacillin/tazobactam for documented Gram-negative infections
GW Patel, N Patel, A Lat, K Trombley, S Enbawe… - … and infectious disease, 2009 - Elsevier
Outcomes of extended infusion piperacillin/tazobactam for documented Gram-negative infections -
ScienceDirect Skip to main contentSkip to article Elsevier logo Journals & Books Search …
ScienceDirect Skip to main contentSkip to article Elsevier logo Journals & Books Search …
Clinical efficacy and pharmacoeconomics of a continuous‐infusion piperacillin‐tazobactam program in a large community teaching hospital
EM Grant, JL Kuti, DP Nicolau… - … : The Journal of …, 2002 - Wiley Online Library
Study Objective. To compare continuous versus intermittent administration of piperacillin‐
tazobactam with regard to clinical, microbiologic, and economic outcomes. Design …
tazobactam with regard to clinical, microbiologic, and economic outcomes. Design …
Pharmacokinetics of piperacillin–tazobactam: intermittent dosing versus continuous infusion
C Buck, N Bertram, T Ackermann, T Sauerbruch… - International journal of …, 2005 - Elsevier
In the present study 24 hospitalized patients requiring empirical antibiotic treatment were
randomly assigned to receive the β-lactam antibiotic/β-lactamase inhibitor combination …
randomly assigned to receive the β-lactam antibiotic/β-lactamase inhibitor combination …
Clinical cure of ventilator-associated pneumonia treated with piperacillin/tazobactam administered by continuous or intermittent infusion
L Lorente, A Jiménez, MM Martín, JL Iribarren… - International journal of …, 2009 - Elsevier
The standard mode of administration of piperacillin treatment is by intermittent infusion.
However, continuous infusion may be advantageous as β-lactam antibiotics exhibit time …
However, continuous infusion may be advantageous as β-lactam antibiotics exhibit time …
Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient …
MH Abdul-Aziz, J Lipman, M Akova… - Journal of …, 2016 - academic.oup.com
Objectives We utilized the database of the Defining Antibiotic Levels in Intensive care unit
patients (DALI) study to statistically compare the pharmacokinetic/pharmacodynamic and …
patients (DALI) study to statistically compare the pharmacokinetic/pharmacodynamic and …
Continuous infusion of β-lactam antibiotics in severe infections: a review of its role
JA Roberts, J Paratz, E Paratz, WA Krueger… - International journal of …, 2007 - Elsevier
Continuous infusion of β-lactam antibiotics has been widely promoted to optimise their time-
dependent activity. Increasing evidence is emerging suggesting potential benefits in patient …
dependent activity. Increasing evidence is emerging suggesting potential benefits in patient …
相关搜索
- meta analysis piperacillin tazobactam
- clinical outcomes piperacillin tazobactam
- meta analysis clinical outcomes
- intravenous infusion piperacillin tazobactam
- intravenous infusion clinical outcomes
- meta analysis intravenous infusion
- continuous infusion severe infections
- dosing strategies piperacillin tazobactam
- continuous infusion pharmacokinetics of piperacillin
- retrospective cohort piperacillin tazobactam
- continuous infusion intermittent dosing
- continuous infusion beta lactam
- dosing strategies clinical outcomes
- meta analysis dosing strategies
- clinical cure piperacillin tazobactam
- clinical efficacy piperacillin tazobactam